Free Trial

Genenta Science (GNTA) Competitors

Genenta Science logo
$3.32 +0.15 (+4.56%)
As of 01:04 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

GNTA vs. CRBU, CLLS, SAVA, BDTX, SLS, EPRX, VOR, TARA, GNFT, and MDWD

Should you be buying Genenta Science stock or one of its competitors? The main competitors of Genenta Science include Caribou Biosciences (CRBU), Cellectis (CLLS), Cassava Sciences (SAVA), Black Diamond Therapeutics (BDTX), SELLAS Life Sciences Group (SLS), Eupraxia Pharmaceuticals (EPRX), Vor Biopharma (VOR), Protara Therapeutics (TARA), GENFIT (GNFT), and MediWound (MDWD). These companies are all part of the "pharmaceutical products" industry.

Genenta Science vs. Its Competitors

Caribou Biosciences (NASDAQ:CRBU) and Genenta Science (NASDAQ:GNTA) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership, risk and media sentiment.

In the previous week, Caribou Biosciences had 2 more articles in the media than Genenta Science. MarketBeat recorded 2 mentions for Caribou Biosciences and 0 mentions for Genenta Science. Caribou Biosciences' average media sentiment score of 1.17 beat Genenta Science's score of 0.00 indicating that Caribou Biosciences is being referred to more favorably in the media.

Company Overall Sentiment
Caribou Biosciences Positive
Genenta Science Neutral

Caribou Biosciences presently has a consensus target price of $6.67, indicating a potential upside of 129.89%. Given Caribou Biosciences' stronger consensus rating and higher possible upside, analysts clearly believe Caribou Biosciences is more favorable than Genenta Science.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Caribou Biosciences
1 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50
Genenta Science
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Genenta Science has a net margin of 0.00% compared to Caribou Biosciences' net margin of -1,800.93%. Genenta Science's return on equity of 0.00% beat Caribou Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Caribou Biosciences-1,800.93% -62.35% -49.65%
Genenta Science N/A N/A N/A

Caribou Biosciences has a beta of 2.59, indicating that its share price is 159% more volatile than the S&P 500. Comparatively, Genenta Science has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500.

Genenta Science has lower revenue, but higher earnings than Caribou Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Caribou Biosciences$9.99M27.03-$149.10M-$1.78-1.63
Genenta ScienceN/AN/A-$9.64MN/AN/A

77.5% of Caribou Biosciences shares are held by institutional investors. Comparatively, 15.1% of Genenta Science shares are held by institutional investors. 9.5% of Caribou Biosciences shares are held by company insiders. Comparatively, 29.0% of Genenta Science shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Caribou Biosciences beats Genenta Science on 8 of the 13 factors compared between the two stocks.

Get Genenta Science News Delivered to You Automatically

Sign up to receive the latest news and ratings for GNTA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GNTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GNTA vs. The Competition

MetricGenenta ScienceMED IndustryMedical SectorNASDAQ Exchange
Market Cap$63.67M$3.47B$6.17B$10.68B
Dividend YieldN/A2.27%5.72%4.83%
P/E RatioN/A23.4029.4727.34
Price / SalesN/A479.21587.77132.79
Price / CashN/A45.2825.8230.35
Price / Book4.4910.5212.446.68
Net Income-$9.64M-$52.71M$3.32B$276.46M
7 Day Performance-4.18%4.72%2.15%0.77%
1 Month Performance14.03%15.59%8.41%3.73%
1 Year Performance-39.55%13.83%61.67%36.59%

Genenta Science Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GNTA
Genenta Science
N/A$3.33
+4.6%
N/A-40.5%$63.67MN/A0.007Gap Down
CRBU
Caribou Biosciences
2.5193 of 5 stars
$2.44
+2.5%
$6.67
+173.2%
+31.5%$227.21M$9.99M-1.37100Positive News
Gap Up
CLLS
Cellectis
2.1623 of 5 stars
$4.18
-5.4%
$4.00
-4.3%
+109.5%$224.56M$49.22M-5.10290Analyst Forecast
Gap Down
SAVA
Cassava Sciences
2.6806 of 5 stars
$4.43
+8.0%
$2.00
-54.9%
-85.2%$214.01MN/A-1.7430
BDTX
Black Diamond Therapeutics
3.9192 of 5 stars
$3.76
-1.2%
$11.00
+192.9%
+21.1%$213.81MN/A16.3390News Coverage
SLS
SELLAS Life Sciences Group
1.2943 of 5 stars
$2.03
+1.5%
$7.00
+244.8%
+69.8%$213.76M$1M-6.3410Gap Up
EPRX
Eupraxia Pharmaceuticals
2.5814 of 5 stars
$5.94
-1.9%
$11.00
+85.3%
+130.3%$213.42MN/A-6.9829Short Interest ↑
High Trading Volume
VOR
Vor Biopharma
2.8548 of 5 stars
$30.77
-4.7%
$113.83
+269.9%
N/A$210.77MN/A-0.11140Insider Trade
Gap Up
TARA
Protara Therapeutics
1.7357 of 5 stars
$5.36
+0.4%
$19.60
+265.7%
+187.4%$206.79MN/A-3.3130
GNFT
GENFIT
1.9411 of 5 stars
$4.10
-3.5%
$7.00
+70.7%
-28.6%$205M$76.77M0.00120Positive News
Gap Down
MDWD
MediWound
1.8839 of 5 stars
$18.47
+1.4%
$32.25
+74.6%
+6.9%$204.83M$20.22M-7.0080

Related Companies and Tools


This page (NASDAQ:GNTA) was last updated on 10/20/2025 by MarketBeat.com Staff
From Our Partners